WO2012173458A2 - 식물 세포 내에 안정화된 활성 물질 및 그 제조방법 - Google Patents
식물 세포 내에 안정화된 활성 물질 및 그 제조방법 Download PDFInfo
- Publication number
- WO2012173458A2 WO2012173458A2 PCT/KR2012/004818 KR2012004818W WO2012173458A2 WO 2012173458 A2 WO2012173458 A2 WO 2012173458A2 KR 2012004818 W KR2012004818 W KR 2012004818W WO 2012173458 A2 WO2012173458 A2 WO 2012173458A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant cells
- active substance
- acid
- plant cell
- stabilized
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Definitions
- the present inventors have tried to develop a method for stabilizing an active substance which is simpler and more biocompatible. As a result, the present invention has been completed by identifying that the stability of the active substance is increased when the active substance is introduced into the plant cell, particularly in the cell wall.
- It is therefore an object of the present invention to provide a cosmetic composition comprising an active substance stabilized in plant cells.
- Another object of the present invention is to provide a method for producing a plant cell comprising the stabilized active substance after stabilizing the active substance.
- One embodiment of the present invention to achieve the above object provides a cosmetic composition containing a plant cell comprising a stabilized active material.
- the active material of the cosmetic composition may be at least one selected from the group consisting of a hydrophilic material and a hydrophobic material.
- the active substance of the cosmetic composition is gallic acid (Gallic acid), amino acids, phytic acid (Phytic acid), vitamin C, L-Ascorbic acid (L-Ascorbic acid), arbutin, fructose Diphosphate, trisodium fructose, 1, 6-diphosphate adenosine, niacinamide, genistein, flavonoids, epigallocatechin gallate (EGCG), retinol, hesperidin, oleanolic acid, polymethyl It may be at least one selected from the group consisting of methacrylate, thymol trimethoxycinnamate, red ginseng saponin, hydrolyzed ginseng saponin and ascorbyl glucoside.
- the plant cell is preferably using a cell wall.
- one embodiment of the present invention provides a method for producing a plant cell comprising the stabilized active material after stabilizing the active material comprising the following steps.
- the active material of the method for producing plant cells may be at least one selected from the group consisting of hydrophilic material and hydrophobic material.
- the active material of the method for producing plant cells is gallic acid (Gallic acid), amino acids, phytic acid (Phytic acid), vitamin C, L-Ascorbic acid (L-Ascorbic acid), Arbutin, Fructose Diphosphate, Trisodium Fructose, 1, 6-Diphosphate Adenosine, Niacinamide, Genistein, Flavonoids, Epigallocatechin Gallate (EGCG), Retinol, Hesperidin, Oleanolic Acid ), Polymethyl methacrylate, thymol trimethoxycinnamate, red ginseng saponin, hydrolyzed ginseng saponin and ascorbyl glucoside.
- 1 is a proof chart showing the process of introducing and stabilizing active substances into plant cells.
- 3A to 3C are graphs showing the results of the component analysis using HPLC chromatograms for Samples 5 to 7, which are hydrophobic active substances used in the present invention, compared with the respective standard reagents.
- 5A to 5C are graphs showing the results of formulation stability after introducing the hydrophobic active substance of the present invention into plant cells.
- the plant cells are preferably used after the attached multi-cells are made into single cells through pretreatment through a combination of enzymes.
- the enzyme may be used any kind of enzyme selected in the art.
- the term "active substance" refers to a substance that enhances or inhibits the function of a living body.
- the active substance may be at least one selected from the group consisting of a hydrophilic substance and a hydrophobic substance.
- the active material may be a hydrophilic material.
- Hydrophilic active substances of the present invention are gallic acid (Gallic acid), amino acids, phytic acid (vitamin), vitamin C, L- Ascorbic acid (L-Ascorbic acid), arbutin, fructose diphosphate, trisodium fructose, 1 , 6-diphosphate adenosine and niacinamide may be one or more selected from the group consisting of, preferably any one or more selected from the group consisting of gallic acid (Gallic acid), amino acids, phytic acid and vitamin C But it is not limited thereto.
- the plant cells preferably use a cell wall.
- solvent solvent refers to any solvent capable of dissolving the active substance, and refers to water, ethanol, ethyl acetate, butylene glycol, methanol, propanediol, and the like.
- the soluble solvent is water, ethanol, methanol, butanol, propanol, propanediol, butylene glycol, propylene glycol, pentylene glycol, hexanediol, chloroform, ethyl acetate , Dichloromethane, hexane, petroleum ether and diethyl ether may be one solvent selected from the group consisting of two or more mixed solvents, preferably water, ethanol, methanol, more preferably water, ethanol.
- the term 'high pressure conditions' used in the present invention means conditions suitable for the introduction of active substances into plant cells, specifically 0.01 MPa-500 MPa, more preferably 0.1 MPa-100 MPa, most preferably 0.5 MPa-20 MPa.
- the method for stabilizing the active substance may further comprise the step of causing a dehydration reaction from the plant cell into which the active substance is introduced in order to increase the intake rate of the active substance, Obtaining the introduced plant cells may be further included.
- reverse osmosis refers to a process of sending a solvent to a lower concentration of solute by applying a pressure greater than osmotic pressure to a lower concentration of solute (Reverse Osmosis (R / O): Selecting a Reverse Osmosis) Unit By Arthur Fisher et.al.
- a method of reverse osmosis can be used by adding a salt containing a sodium or potassium element.
- Obtaining plant cells into which the active substance has been introduced includes methods for cell harvesting that are commonly used, but methods of obtaining through filters or / and centrifugation may be used. When using a filter, 1.2-50 um and 40-200 mesh are preferable, and when using centrifugation, 100-9,000 rpm and 0-25 degreeC are preferable.
- the content of the stabilized active substance in the plant cells is preferably contained in an amount of 0.001 to 10% by weight relative to the total weight of the cosmetic composition, it does not exhibit activity at 0.001% or less and the feeling of use of the formulation at 10% or more Affects stability.
- Gallic acid (> 99%, Sigma, USA) was added to 10% by weight of tertiary distilled water and stirred for 30 minutes. Subsequently, 10% by weight of soluble gallic acid and 10% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 80% by weight of distilled water, and then a propeller mixer (BL3000, Heidon, JPN) was used. And stirred at 800 rpm, 20 °C, conditions for 1 hour. After stirring, the plant cell mixture was added with high pressure at 20 MPa, 25 ° C. for 1 hour using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- a propeller mixer BL3000, Heidon, JPN
- 2% by weight of sodium chloride (Sodium Chloride, NaCl) was added to the plant cell mixture, which was subjected to high pressure, using a propeller mixer (BL3000, Heidon, JPN) to induce reverse osmosis for 1 hour at 800 rpm, 20 ° C., and dehydration. Thereafter, centrifuge (Supra 22K, Hanil, KOR) using a centrifuge at 9,000 rpm, 15 °C high-speed centrifugation for 20 minutes to obtain a plant cell in which the active material is introduced.
- a propeller mixer BL3000, Heidon, JPN
- Amino acid (AAS, Agilent, USA) was added to 20% by weight of distilled water and stirred for 30 minutes. Subsequently, 20% by weight of the amino acid solubles and 1% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 79% by weight of distilled water and then 800rpm using a propeller mixer (BL3000, Heidon, JPN). Stirred at 20 ° C. for 1 hour. After stirring, the plant cell mixture was added with high pressure at 20 MPa, 25 ° C. for 1 hour using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- TFS-2L TOYO KOATSU CO., LTD., JPN
- sample 2 The plant cells were washed with 100-fold saline (0.9% NaCl aqueous solution) and then centrifuged at 9,000 rpm and 15 ° C for 20 minutes using a centrifuge (Supra 22K, Hanil, KOR). Samples were obtained. This thus obtained was referred to as "sample 2" and was used in the following test example.
- Phytic acid 50% (w / w), Sigma, USA was added to the tertiary distilled water at 10% by weight and stirred for 30 minutes. Thereafter, 10% by weight of phytic acid solubles and 10% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 80% by weight of distilled water, using a propeller mixer (BL3000, Heidon, JPN). Stirred at 800 rpm, 20 ° C, conditions for 1 hour. After stirring, the plant cell mixture was subjected to high pressure for 1 hour at 20 MPa and 25 ° C using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- a high pressure device TFS-2L, TOYO KOATSU CO., LTD., JPN
- 2% by weight of sodium chloride (Sodium Chloride, NaCl) was added to the plant cell mixture, which was subjected to high pressure, using a propeller mixer (BL3000, Heidon, JPN) to induce reverse osmosis for 1 hour at 800 rpm, 20 ° C., and dehydration. Thereafter, centrifuge (Supra 22K, Hanil, KOR) using a centrifuge at 9,000 rpm, 15 °C high-speed centrifugation for 20 minutes to obtain a plant cell in which the active material is introduced.
- a propeller mixer BL3000, Heidon, JPN
- sample 3 The plant cells were washed with 100-fold saline solution (0.9% NaCl solution) and then centrifuged (Supra 22K, Hanil, KOR) for 20 minutes at 9,000 rpm and 15 ° C using a centrifuge. To obtain a sample. This thus obtained was referred to as "sample 3" and was used in the following test example.
- L-ascorbic acid > 99%, Samchun, KOR
- 10% by weight of ascorbic acid solubles and 10% by weight of plant cells Black soybean unicell, Healthy food ingredient Co., Ltd., JPN
- BL3000, Heidon, JPN a propeller mixer
- the plant cell mixture was subjected to high pressure for 1 hour at 20 MPa and 25 ° C using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- 2% by weight of sodium chloride (Sodium Chloride, NaCl) was added to the plant cell mixture, which was subjected to high pressure, using a propeller mixer (BL3000, Heidon, JPN) to induce reverse osmosis for 1 hour at 800 rpm, 20 ° C., and dehydration. Thereafter, centrifuge (Supra 22K, Hanil, KOR) using a centrifuge at 9,000 rpm, 15 °C high-speed centrifugation for 20 minutes to obtain a plant cell in which the active material is introduced.
- a propeller mixer BL3000, Heidon, JPN
- sample 4" The plant cells were washed with 100-fold saline (0.9% NaCl aqueous solution) and then centrifuged at 9,000 rpm and 15 ° C for 20 minutes using a centrifuge (Supra 22K, Hanil, KOR). Samples were obtained. This thus obtained was referred to as "sample 4" and was used in the following test example.
- Genistein (> 99%, Sigma, USA) was added to 99.5% ethyl alcohol (Ethyl Alcohol, Ethanol) 5% by weight and stirred for 30 minutes. Subsequently, 10% by weight of Zenysteine solubles and 10% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 80% by weight of distilled water, and then 800 rpm using a propeller mixer (BL3000, Heidon, JPN). Stirred at 20 ° C. for 1 hour. After stirring, the plant cell mixture was subjected to high pressure for 1 hour at 20 MPa and 25 ° C using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- a high pressure device TFS-2L, TOYO KOATSU CO., LTD., JPN
- 2% by weight of sodium chloride (Sodium Chloride, NaCl) was added to the plant cell mixture, which was subjected to high pressure, using a propeller mixer (BL3000, Heidon, JPN) to induce reverse osmosis for 1 hour at 800 rpm, 20 ° C., and dehydration. Thereafter, centrifuge (Supra 22K, Hanil, KOR) using a centrifuge at 9,000 rpm, 15 °C high-speed centrifugation for 20 minutes to obtain a plant cell in which the active material is introduced.
- a propeller mixer BL3000, Heidon, JPN
- sample 5" The plant cells were washed with 100-fold saline (0.9% NaCl aqueous solution) and then centrifuged at 9,000 rpm and 15 ° C for 20 minutes using a centrifuge (Supra 22K, Hanil, KOR). Samples were obtained. This thus obtained was referred to as "sample 5" and was used in the following test example.
- Epigallocatechin gallate > 99%, Sigma, USA was added to 5% by weight of 70% ethyl alcohol (Ethyl Alcohol, Ethanol) aqueous solution and stirred for 30 minutes. Then, 10% by weight of epigallocatechin gallate (EGCG) solubles and 10% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 80% by weight of distilled water and then a propeller mixer (BL3000, Heidon, JPN) was stirred at 800 rpm, 20 °C, conditions for 1 hour. After stirring, the plant cell mixture was added with high pressure at 20 MPa, 25 ° C.
- EGCG epigallocatechin gallate
- JPN propeller mixer
- sample 6 The plant cells were washed with 100-fold physiological saline solution (0.9% NaCl solution) and then centrifuged at 9,000 rpm and 15 ° C for 20 minutes using a centrifuge (Supra 22K, Hanil, KOR). Samples were obtained. This thus obtained was referred to as “sample 6", and was used in the following test examples.
- Retinol (> 99%, Sigma, USA) was added to 5% by weight of 99.5% ethyl alcohol (Ethyl Alcohol, Ethanol) aqueous solution and stirred for 30 minutes. Subsequently, 10% by weight of retinol solubles and 10% by weight of plant cells (Black soybean unicell, Healthy food ingredient Co., Ltd., JPN) were added to 80% by weight of distilled water and 800 rpm using a propeller mixer (BL3000, Heidon, JPN). Stirred at 20 ° C. for 1 hour.
- ethyl alcohol Ethyl Alcohol, Ethanol
- the plant cell mixture was subjected to high pressure for 1 hour at 20 MPa and 25 ° C using a high pressure device (TFS-2L, TOYO KOATSU CO., LTD., JPN).
- 2% by weight of sodium chloride (Sodium Chloride, NaCl) was added to the plant cell mixture, which was subjected to high pressure, using a propeller mixer (BL3000, Heidon, JPN) to induce reverse osmosis for 1 hour at 800 rpm, 20 ° C., and dehydration.
- HPLC high performance liquid chromatography
- Samples were prepared with a suitable concentration in each solvent, filtered through a 0.2 um disk filter, pretreated and injected into the instrument.
- the instrument was analyzed in the UV 254-340 nm region using high performance liquid chromatography (Agilent Technologies 1200 Series HPLC, Agilent, USA) and 2% using C18 column (Zorbax XDB-C18 4.6 x 250mm, Agilent, USA). It was analyzed by the gradient method using an acetic acid solvent and acetonitrile (ACN) solvent.
- the solvent used in the analysis was an HPLC grade reagent, and the component analysis was performed using gallic acid (> 99%, Sigma, USA) as a standard.
- the analysis results are shown in [Figure 2a], [Table 1].
- the sample was prepared with a suitable concentration in each solvent, filtered through a 0.2 um disk filter, and after pretreatment, o-phthalaldehyde (o-phthalaldehyde, OPA Agilent), 9 Fluorescence detector (FLD) using high-performance liquid chromatography (Agilent Technologies 1200 Series HPLC, Agilent, USA) after formation of fluorescent isoindole using 9-fluorenylmethylchloroformate.FMOC derivative , Agilent Technologies, USA), and the calibration curve was prepared using a 250 pM Amino Acid Analysis Standard (AAS, Agilent, USA) as a standard, and component analysis was performed. The analysis results are shown in [FIG. 2B] and [Table 1].
- a sample was prepared with a suitable concentration in each solvent, filtered through a 0.2 um disk filter, and then subjected to high-performance liquid chromatography (Agilent Technologies 1200 Series).
- the phytic acid was detected by using an evaporative light scattering detector (ELSD 3300, Alltech, USA) using HPLC, Agilent, USA.
- the eluate was tertiary distilled water, the column temperature was 25 ° C, and the flow rate was 0.5 ml / min.
- a calibration curve was prepared using L-ascorbic acid (> 99%, Samchun, KOR) as a standard, and component analysis was performed. The analysis results are shown in [FIG. 2D] and [Table 1].
- the content of the stabilizing sample in the hydrophilic active substance plant cells using high performance liquid chromatography is shown in Table 1 below, and the encapsulation efficiency is calculated and expressed based on Equation 1 below.
- HPLC high performance liquid chromatography
- Samples were prepared with appropriate concentrations in each solvent, filtered through a 0.2 um disc filter, pretreated and injected into the instrument.
- the instrument was analyzed in the UV 254-340 nm region using high performance liquid chromatography (Agilent Technologies 1200 Series HPLC, Agilent, USA) and 2% using C18 column (Zorbax XDB-C18 4.6 x 250mm, Agilent, USA). It was analyzed by the gradient method using an acetic acid solvent and acetonitrile (ACN) solvent.
- ACN acetonitrile
- the solvent used in the analysis was a high-performance liquid chromatography-class reagent, and the component analysis was performed using Genistein (> 99%, Sigma, USA) as a standard.
- Genistein > 99%, Sigma, USA
- the analysis results are shown in [FIG. 3A] and [Table 2].
- EGCG epigallocatechin gallate
- HPLC high performance liquid chromatography
- Samples were prepared with a suitable concentration in each solvent, filtered through a 0.2 um disk filter, pretreated and injected into the instrument.
- the instrument was analyzed in the UV 254-340 nm region using high performance liquid chromatography (Agilent Technologies 1200 Series HPLC, Agilent, USA) and 2% using C18 column (Zorbax XDB-C18 4.6 x 250mm, Agilent, USA). It was analyzed by the gradient method using an acetic acid solvent and acetonitrile (ACN) solvent.
- ACN acetonitrile
- the solvent used in the analysis was a high-performance liquid chromatography-grade reagent, and the component analysis was performed using epigallocatechin gallate (> 99%, Sigma, USA) as a standard.
- the analysis results are shown in [FIG. 3B] and [Table 2].
- HPLC high performance liquid chromatography
- the solvent used in the analysis was a high-performance liquid chromatography-grade reagent, and the component analysis was performed using retinol (> 99%, Sigma, USA) as a standard.
- the analysis results are shown in [FIG. 3C] and [Table 2].
- the content of the stabilizing sample in the hydrophobic active material plant cells using high performance liquid chromatography is shown in Table 2 below, and the encapsulation efficiency was calculated based on Equation 1 above.
- Component composition of the nutrient cream containing the gallic acid stabilized in the plant cell according to Example 1 was prepared by configuring as shown in Table 3 below.
- the aqueous components of the raw materials 12 to 18 are completely dissolved by heating to 80 ° C., and then the raw materials 1 to 11 are heated to 80 ° C. and added to the solution of the raw materials 12 to 18 and homomixer (Homo Mixer Mark II, Primix, JPN) was emulsified at 3000 rpm for 15 minutes. Then, the raw material 19 was thrown in, stirred for 5 minutes, and cooled to room temperature.
- homomixer Homo Mixer Mark II, Primix, JPN
- Component composition of the nutrient cream containing amino acids stabilized in the plant cell according to Example 2 was prepared as shown in the [Table 4].
- the aqueous components of the raw materials 12 to 18 are completely dissolved by heating to 80 ° C., and then the raw materials 1 to 11 are heated to 80 ° C. and added to the solution of the raw materials 12 to 18 and homomixer (Homo Mixer Mark II, Primix, JPN) was emulsified at 3000 rpm for 15 minutes. Then, the raw material 19 was thrown in, stirred for 5 minutes, and cooled to room temperature.
- homomixer Homo Mixer Mark II, Primix, JPN
- Component composition of the nutrient cream containing phytic acid stabilized in the plant cell according to Example 3 was prepared as shown in Table 5 below.
- the aqueous components of the raw materials 12 to 18 are completely dissolved by heating to 80 ° C., and then the raw materials 1 to 11 are heated to 80 ° C. and added to a solution of the raw materials 12 to 18 and homomixer (Homo Mixer Mark II, Primix, JPN) was emulsified at 3000 rpm for 15 minutes. Thereafter, the raw material 19 was added and stirred for 5 minutes, and then cooled to room temperature.
- homomixer Homo Mixer Mark II, Primix, JPN
- Component composition of the nutrient cream containing vitamin C stabilized in the plant cell according to Example 4 was prepared by configuring as shown in Table 6.
- composition of the nutrition cream including epigallocatechin gallate (EGCG) stabilized in the plant cells according to Example 6 was prepared as shown in Table 8 below.
- the aqueous components of the raw materials 12 to 16 and 18 are completely dissolved by heating to 80 ° C., and then the raw materials 1 to 11 and 17 are heated to 80 ° C. to prepare the raw materials 12 to 16 and 18.
- the solution was added and emulsified at 3000 rpm for 15 minutes using a Homo Mixer Mark II, Primix, JPN. Then, the raw material 19 was thrown in, stirred for 5 minutes, and cooled to room temperature.
- Table 10 shows an example of the flexible longevity formulation [Formulation Example 1].
- Table 11 shows the formulation examples of convergent longevity [Formulation Example 2].
- Table 14 shows the formulation of the pack [Formulation 5].
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
시 료 | 활성 물질 종류 | 함량 (%) | 봉입효율 (%) | 비고 |
시료 1 | 갈릭산 | 2.80 | 28.0 | |
시료 2 | 아미노산 | 0.03 | 37.5 | |
시료 3 | 피트산 | 0.54 | 10.8 | |
시료 4 | 비타민C | 3.11 | 15.6 |
시 료 | 활성 물질 종류 | 함량(%) | 봉입효율(%) | 비고 |
시료 5 | 제니스테인 | 0.35 | 7.0 | |
시료 6 | 에피갈로카테킨 갈레이트 | 1.21 | 24.2 | |
시료 7 | 레티놀 | 0.41 | 8.2 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 1 | 2.0 | - |
17 | 갈릭산 | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 2 | 2.0 | - |
17 | 아미노산 표준물 | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 3 | 2.0 | - |
17 | 피트산 | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 4 | 2.0 | - |
17 | 비타민C | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 5 | 2.0 | - |
17 | 제니스테인 | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 6 | 2.0 | - |
17 | EGCG | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 제형 실시예 1 | 제형 비교예 1 |
1 | 친유형 모노스테아린산글리세린 | 2.0 | 2.0 |
2 | 스테아린산 | 1.5 | 1.5 |
3 | 세테아릴 알콜 | 2.2 | 2.2 |
4 | 밀납 | 1.0 | 1.0 |
5 | 스쿠알란 | 3.0 | 3.0 |
6 | 경화식물유 | 1.0 | 1.0 |
7 | 소르비탄 스테아레이트 | 0.6 | 0.6 |
8 | 광물유 | 5.0 | 5.0 |
9 | 폴리솔베이트 60 | 1.5 | 1.5 |
10 | 디메치콘 | 1.0 | 1.0 |
11 | 트리옥타노인 | 5.0 | 5.0 |
12 | 베타인 | 3.0 | 3.0 |
13 | 트리에탄올아민 | 1.0 | 1.0 |
14 | 글리세린 | 5.0 | 5.0 |
15 | 소듐히아루로네이트 | 3.0 | 3.0 |
16 | 시료 7 | 2.0 | - |
17 | 레티놀 | - | 2.0 |
18 | 증류수 | 잔량 | 잔량 |
19 | 방부제, 향, 색소 | 미량 | 미량 |
번호 | 성 분 | 함량(%) |
1 | 글리세린 | 5.00 |
2 | 1,3-부틸렌 글라이콜 | 3.00 |
3 | PEG 1500 | 1.00 |
4 | 알란토인 | 0.10 |
5 | DL-판테놀 | 0.30 |
6 | EDTA-2Na | 0.02 |
7 | 벤조페논-9 | 0.04 |
8 | 에탄올 | 10.00 |
9 | 옥틱도데세스-16 | 0.20 |
10 | 폴리솔베이트 20 | 0.20 |
11 | 식물 세포 내에 안정화된 활성 물질 | 5.0 |
12 | 방부제, 향, 색소 | 미량 |
13 | 증류수 | 잔량 |
번호 | 성 분 | 함량(%) |
1 | 글리세린 | 2.00 |
2 | 1,3-부틸렌 글라이콜 | 2.00 |
3 | 알란토인 | 0.10 |
4 | DL-판테놀 | 0.30 |
5 | EDTA-2Na | 0.02 |
6 | 벤조페논-9 | 0.04 |
7 | 에탄올 | 15.00 |
8 | 폴리솔베이트 20 | 0.20 |
9 | 식물 세포 내에 안정화된 활성 물질 | 3.0 |
10 | 구연산 | 미량 |
11 | 방부제, 향, 색소 | 미량 |
12 | 증류수 | 잔량 |
번호 | 성 분 | 함량(%) |
1 | 세테아릴 알콜 | 1.00 |
2 | 글리세릴스테아레이트 | 0.50 |
3 | 폴리소르베이트 60 | 1.00 |
4 | 소르비탄세스퀴올리에이트 | 0.30 |
5 | 세틸옥타노에이트 | 6.00 |
6 | 스쿠알란 | 4.00 |
7 | 샤플라워오일 | 4.00 |
8 | 부틸렌글라이콜 | 4.00 |
9 | 글리세린 | 4.00 |
10 | 카보머 | 0.10 |
11 | 트리에탄올아민 | 0.10 |
12 | 식물 세포 내에 안정화된 활성 물질 | 1.00 |
13 | 방부제, 향, 색소 | 미량 |
14 | 증류수 | 잔량 |
번호 | 성 분 | 함량(%) |
1 | 글리세린 | 10.00 |
2 | 베타인 | 5.00 |
3 | PEG 1500 | 2.00 |
4 | 알란토인 | 0.10 |
5 | DL-판테놀 | 0.30 |
6 | EDTA-2Na | 0.02 |
7 | 벤조페논-9 | 0.04 |
8 | 히드록시에틸 셀룰로오스 | 0.10 |
9 | 카르복시비닐 폴리머 | 0.20 |
10 | 트리에탄올아민 | 0.18 |
11 | 옥틸도데칸올 | 0.30 |
12 | 옥틸도데세스-16 | 0.40 |
13 | 에탄올 | 6.00 |
14 | 식물 세포 내에 안정화된 활성 물질 | 5.00 |
15 | 방부제, 향, 색소 | 미량 |
16 | 증류수 | 잔량 |
번호 | 성 분 | 함량(%) |
1 | 폴리비닐 알콜 | 15.00 |
2 | 셀룰로오스 검 | 0.15 |
3 | 글리세린 | 3.00 |
4 | PEG 1500 | 2.00 |
5 | 시이크데스트린 | 0.15 |
6 | DL-판테놀 | 0.30 |
7 | 알란토인 | 0.10 |
8 | 글리시리진산 모노암모늄 | 0.20 |
9 | 니코틴 아미드 | 0.40 |
10 | 에탄올 | 5.00 |
11 | PEG 40 경화피마자유 | 0.30 |
12 | 식물 세포 내에 안정화된 활성 물질 | 1.00 |
13 | 방부제, 향, 색소 | 미량 |
14 | 증류수 | 잔량 |
Claims (8)
- 안정화된 활성 물질을 포함하는 식물 세포를 함유하는 화장료 조성물.
- 제 1 항에 있어서,상기 활성 물질은 친수성 물질 및 소수성 물질로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 화장료 조성물.
- 제 1 항에 있어서,상기 활성 물질은 갈릭산(Gallic acid), 아미노산, 피트산(Phytic acid), 비타민 C, L-아스코르브산(L-Ascorbic acid), 알부틴, 프룩토스 디포스페이트, 트리소듐 프룩토스, 1, 6-디포스페이트 아데노신, 나이아신아마이드, 제니스테인(Genistein), 플라보노이드, 에피갈로카테킨 갈레이트(EGCG), 레티놀, 헤스페리딘, 올레아노릭산(Oleanolic Acid), 폴리메틸 메타크리레이트, 티몰트리메톡시신나메이트(Thymol Trimethoxycinnamate), 홍삼 사포닌, 하이드롤라이즈드 인삼사포닌 및 아스코빌글루코사이드로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 화장료 조성물.
- 제 1 항에 있어서,상기 식물 세포는 세포벽임을 특징으로 하는 화장료 조성물.
- 다음의 단계를 포함하는 활성 물질을 안정화시킨 후 안정화된 활성 물질을 포함하는 식물 세포를 제조하는 방법.(a) 1-100 MPa 의 조건에서 식물 세포 내에 활성 물질을 인입시키는 단계 ;(b) 활성 물질이 인입된 식물 세포로부터 역삼투화를 이용해 탈수반응을 일으키는 단계 ; 및(c) 활성 물질이 인입된 식물 세포를 수득하는 단계.
- 제 5 항에 있어서,상기 활성 물질은 친수성 및 소수성으로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 식물 세포를 제조하는 방법.
- 제 5 항에 있어서,상기 활성 물질은 갈릭산(Gallic acid), 아미노산, 피트산(Phytic acid), 비타민 C, L-아스코르브산(L-Ascorbic acid), 알부틴, 프룩토스 디포스페이트, 트리소듐 프룩토스, 1, 6-디포스페이트 아데노신, 나이아신아마이드, 제니스테인(Genistein), 플라보노이드, 에피갈로카테킨 갈레이트(EGCG), 레티놀, 헤스페리딘, 올레아노릭산(Oleanolic Acid), 폴리메틸 메타크리레이트, 티몰트리메톡시신나메이트(Thymol Trimethoxycinnamate), 홍삼 사포닌, 하이드롤라이즈드 인삼사포닌 및 아스코빌글루코사이드로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 식물 세포를 제조하는 방법.
- 제 5 항에 있어서,상기 식물 세포는 세포벽임을 특징으로 하는 식물 세포를 제조하는 방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014515767A JP6151686B2 (ja) | 2011-06-16 | 2012-06-18 | 植物細胞内において安定化した活性物質およびその製造方法 |
CN201280035167.0A CN103648481B (zh) | 2011-06-16 | 2012-06-18 | 在植物细胞中保持稳定的活性物质及其制备方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110058758A KR101855919B1 (ko) | 2011-06-16 | 2011-06-16 | 식물 세포 내에 안정화된 활성 물질 및 그 제조방법 |
KR10-2011-0058758 | 2011-06-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012173458A2 true WO2012173458A2 (ko) | 2012-12-20 |
WO2012173458A9 WO2012173458A9 (ko) | 2013-03-07 |
WO2012173458A3 WO2012173458A3 (ko) | 2013-04-25 |
Family
ID=47357643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/004818 WO2012173458A2 (ko) | 2011-06-16 | 2012-06-18 | 식물 세포 내에 안정화된 활성 물질 및 그 제조방법 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6151686B2 (ko) |
KR (1) | KR101855919B1 (ko) |
CN (1) | CN103648481B (ko) |
WO (1) | WO2012173458A2 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150076475A (ko) | 2013-12-27 | 2015-07-07 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체, 이의 제조방법 및 이를 포함하는 화장료 조성물 |
KR20160068190A (ko) | 2014-12-05 | 2016-06-15 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체의 안정화 방법 |
KR20160106268A (ko) | 2015-03-02 | 2016-09-12 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체 함유 마이크로캡슐 및 이를 함유하는 화장료 조성물 |
CN114588100A (zh) * | 2020-12-04 | 2022-06-07 | 韩国百鸥思特公司 | 大量含有愈伤组织代谢产物的愈伤组织溶解产物及其制备方法 |
US11980733B2 (en) | 2014-08-19 | 2024-05-14 | Lutronic Corporation | Apparatus for forming delivery path for composition for treatment and auxiliary assembly for skin treatment including same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7364497B2 (ja) * | 2020-03-04 | 2023-10-18 | トヨタ自動車株式会社 | 緑茶抽出物含有組成物、機能性食品 |
CN115778891A (zh) * | 2022-12-26 | 2023-03-14 | 新生活化妆品科技(上海)有限公司 | 一种化妆品原料及其制备方法与应用、以及化妆品 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000028547A (ko) * | 1998-10-24 | 2000-05-25 | 손경식 | 싱글셀-식물로부터 회수한 유용성분이 함유된 화장료 조성물 |
KR20050041259A (ko) * | 2003-10-30 | 2005-05-04 | 윤성용 | 천연 화장품 개발을 위한 캘러스의 용도 |
KR20060118571A (ko) * | 2003-12-29 | 2006-11-23 | 바이오테크마린 | 피부 탈색 및/또는 미백 목적의 탈분화된 식물 세포의동결건조물의 용도 |
WO2008148828A1 (en) * | 2007-06-08 | 2008-12-11 | Nestec S.A. | Fruit fiber gel |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4038342C1 (ko) * | 1990-12-01 | 1992-01-16 | Boehringer Ingelheim Kg, 6507 Ingelheim, De | |
JP3142245B2 (ja) * | 1996-06-28 | 2001-03-07 | 株式会社資生堂 | 皮膚外用剤 |
JP2002193734A (ja) * | 2000-12-27 | 2002-07-10 | Shiseido Co Ltd | 外用組成物 |
KR100463167B1 (ko) * | 2001-04-13 | 2004-12-23 | 주식회사 태평양 | 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물 |
JP3793465B2 (ja) * | 2002-01-28 | 2006-07-05 | 株式会社オードファブール | 大豆を単細胞に分離して得られる粉末を含有する化粧料組成物 |
JP4939936B2 (ja) * | 2003-06-27 | 2012-05-30 | 株式會社アモーレパシフィック | 生理活性成分を含有する自己集合性高分子ナノ粒子の製造方法、及び得られた自己集合性高分子ナノ粒子を含有する外用剤組成物 |
CN101732228B (zh) * | 2010-02-01 | 2011-12-21 | 云南龙润茶业集团有限公司 | 一种茶面膜及其制备方法 |
-
2011
- 2011-06-16 KR KR1020110058758A patent/KR101855919B1/ko active IP Right Grant
-
2012
- 2012-06-18 WO PCT/KR2012/004818 patent/WO2012173458A2/ko active Application Filing
- 2012-06-18 CN CN201280035167.0A patent/CN103648481B/zh not_active Expired - Fee Related
- 2012-06-18 JP JP2014515767A patent/JP6151686B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000028547A (ko) * | 1998-10-24 | 2000-05-25 | 손경식 | 싱글셀-식물로부터 회수한 유용성분이 함유된 화장료 조성물 |
KR20050041259A (ko) * | 2003-10-30 | 2005-05-04 | 윤성용 | 천연 화장품 개발을 위한 캘러스의 용도 |
KR20060118571A (ko) * | 2003-12-29 | 2006-11-23 | 바이오테크마린 | 피부 탈색 및/또는 미백 목적의 탈분화된 식물 세포의동결건조물의 용도 |
WO2008148828A1 (en) * | 2007-06-08 | 2008-12-11 | Nestec S.A. | Fruit fiber gel |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150076475A (ko) | 2013-12-27 | 2015-07-07 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체, 이의 제조방법 및 이를 포함하는 화장료 조성물 |
US11980733B2 (en) | 2014-08-19 | 2024-05-14 | Lutronic Corporation | Apparatus for forming delivery path for composition for treatment and auxiliary assembly for skin treatment including same |
KR20160068190A (ko) | 2014-12-05 | 2016-06-15 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체의 안정화 방법 |
KR20160106268A (ko) | 2015-03-02 | 2016-09-12 | 코웨이 주식회사 | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체 함유 마이크로캡슐 및 이를 함유하는 화장료 조성물 |
CN114588100A (zh) * | 2020-12-04 | 2022-06-07 | 韩国百鸥思特公司 | 大量含有愈伤组织代谢产物的愈伤组织溶解产物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103648481A (zh) | 2014-03-19 |
KR20120139137A (ko) | 2012-12-27 |
WO2012173458A9 (ko) | 2013-03-07 |
JP2014530800A (ja) | 2014-11-20 |
CN103648481B (zh) | 2016-11-09 |
WO2012173458A3 (ko) | 2013-04-25 |
KR101855919B1 (ko) | 2018-05-09 |
JP6151686B2 (ja) | 2017-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012173458A9 (ko) | 식물 세포 내에 안정화된 활성 물질 및 그 제조방법 | |
KR100793912B1 (ko) | 베타 엔돌핀의 생성을 유도하는 올리고당의 용도 | |
WO2016200190A1 (ko) | 칠엽담으로부터 분리된 지페노사이드를 포함하는 주름 개선용 화장료 조성물 | |
WO2016159665A2 (ko) | 베리과 열매를 섭취한 달팽이 점액을 함유하는 화장료 조성물 및 그의 제조방법 | |
WO2017026855A1 (ko) | 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 피부상태 개선용 조성물 | |
WO2020122360A1 (ko) | 트리신 함량이 증가된 고장초 효소 처리 추출물의 제조방법 및 이로 제조된 미백, 주름 개선, 항염증, 항알러지, 보습용 조성물 | |
WO2022050559A1 (ko) | 데이노잔틴 발효추출물의 제조방법 및 데이노잔틴 발효추출물을 포함하는 화장료 조성물 | |
WO2020076101A1 (ko) | 시지지움 포르모슘 추출물을 유효성분으로 포함하는 피부 미백, 항균 또는 항아토피 조성물 | |
WO2010064878A2 (ko) | 레온토포딕산을 유효성분으로 함유하는 주름개선용 피부 화장료 조성물 | |
WO2021029541A1 (ko) | 수크로오스계 계면활성제를 포함하는 탄성 리포좀 조성물 및 이를 함유하는 화장료 조성물 | |
WO2017200288A1 (ko) | 천연 한방 추출물을 유효성분으로 포함하는 미백, 피부 노화 방지 또는 피부 주름 개선용 조성물 | |
WO2010058982A2 (en) | Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily | |
WO2019088402A1 (ko) | 뷔베리신 또는 뷔베리신 유도체를 유효성분으로 포함하는 피부 미백용 조성물 | |
WO2018139809A1 (ko) | 진세노사이드 함량이 증진된 인삼꽃 추출물을 유효성분으로 포함하는 조성물 | |
WO2014168433A2 (ko) | 발모 및 흰머리 멜라닌 색소 재생과 피부 재생 촉진용 물질 조성물 | |
WO2017119535A1 (ko) | 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물 | |
WO2023171873A1 (ko) | 고형 지질 복합 나노 에토좀 및 이의 제조방법 | |
WO2019027239A2 (ko) | 탈모 방지 또는 발모 촉진용 조성물 | |
WO2017090970A1 (ko) | 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 자외선에 대한 피부 보호용 조성물 | |
WO2016017894A1 (ko) | 밭벼 추출물을 포함하는 화장료 조성물 및 이의 제조방법 | |
KR20190079338A (ko) | 개나리 꽃 추출물의 분획물을 유효성분으로 포함하는 화장료 조성물 | |
WO2021095966A1 (ko) | 클로렐라 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 | |
WO2011038472A1 (pt) | Estrato vegetal padronizado, processo para preparaçâo de extrato de plantas do gênero sclerolobium, composiçâo cosmética, composição farmacêutica e uso do referido extrato | |
WO2018151563A1 (ko) | 코스모스 추출물을 포함하는 광노화 방지 및 피부주름 개선용 조성물 | |
WO2023120763A1 (ko) | 자연유래 식물 핑거루트의 피부탄력 성분 소재를 활용한 에멀젼 제형의 피부탄력 개선 화장료, 이의 제조방법 및 에멀젼 제형 피부탄력 개선 화장품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12800975 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2014515767 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 02/04/2014) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12800975 Country of ref document: EP Kind code of ref document: A2 |